HIV Diagnosis Market by Product Type (Consumables, Assay, and Kits and Reagents), Test Type (Antibody Tests, CD4 Count, Viral Load, Early Infant, and Viral Identification), Application (Diagnostic Laboratories, Hospitals, Blood Banks, and Home Care Settings), and by Region (North America, Europe, Asia Pacific, South America, Middle East, and Africa) Global Trends and Forecast from 2022 to 2029

Published on: Oct 2023
From:USD $3499.00

Please Choose License Type

Single User

Team User

Corporate License

Request a Sample

INTERESTED IN THIS RESEARCH?

Contact our analysts for inquiries, samples, and expert insights.

Market Size	CAGR	Dominating Region
USD 8.68 billion by 2029	10.6%	North American

By Product Type	By Test Type	By Application
Consumables Assay Kits and Reagents	Antibody Tests CD4 Count Viral Load Early Infant Viral Identification	Diagnostic Laboratories Hospitals Blood Banks Home Care Settings

5/5 - (14 votes)

HIV Diagnosis Market Overview:

The global HIV diagnosis market was valued at USD 4.29 billion in 2022 and is projected to reach USD 8.68 billion by 2029, growing at a CAGR of 10.6% from 2022 to 2029.

Human immunodeficiency virus, or HIV for short, is a virus that disrupts the body’s defense mechanisms against dangerous illnesses and infections. It is possible to contract HIV by contact with contaminated sperm, blood, or vaginal secretions. Thus, using the human immunodeficiency virus (HIV), doctors may identify if a person is HIV positive or negative. HIV can typically be found 18 to 45 days after exposure using an antigen/antibody test conducted by a lab on blood from a vein. Additionally, a quick finger-stick antigen/antibody test is available. Testing for antigens and antibodies using fingerstick blood can take anywhere between 18- and 90-days following exposure.

HIV Diagnosis Market | Exactitude Consultancy

The availability of simple, quick assays with visual testing and simple, user-friendly methods for gathering samples at home that can be used by medical professionals and patients is expected to increase the demand for HIV diagnostics. The market for HIV diagnostics has expanded as a result of these reasons, which have also increased the sales of HIV diagnostic methods.

As it may identify the presence of the human immunodeficiency virus (HIV), which causes acquired immunodeficiency syndrome, the need for HIV diagnostics is rising. Testing on serum, saliva, or urine samples is used in HIV diagnoses. As these methods help in the detection of antibodies, antigens, and RNA, it is predicted that the sales of HIV diagnostic procedures would increase. Additionally, as people become more knowledgeable about HIV, the confidentiality of the test, and appropriate counseling, there is a rising need for HIV diagnostics. These reasons are expected to cause the market for HIV diagnostics to expand quickly.

ATTRIBUTE	DETAILS
Study period	2022-2029
Base year	2021
Estimated year	2022
Forecasted year	2022-2029
Historical period	2018-2020
Unit	Value (USD Billion)
Segmentation	By Product Type, Test Type, Application, and Region.
By Product	Consumables Assay Kits and Reagents
By Test Type	Antibody Tests CD4 Count Viral Load Early Infant Viral Identification
By Application	Diagnostic Laboratories Hospitals Blood Banks Home Care Settings
By Region	North America Europe Asia Pacific South America Middle East and Africa

HIV Diagnosis Market Segment Analysis:

Based on product type, test type, application, and region, the global market for HIV diagnosis is divided into these categories.

On the basis of product type HIV diagnosis market is subdivided into consumables, assays, kits, and Reagents. The market’s highest share is anticipated to go to the consumables sector. The market for HIV diagnosis worldwide was dominated by the consumer goods industry. The market for HIV diagnostics is growing as a result of increased consumption of consumables such as tests, reagents, and kits. Some of the key reasons driving the consumables market are the rising prevalence of HIV/AIDS, the increasing number of government programs to combat HIV/AIDS, and the regular and repetitive purchases of consumables by laboratories and hospitals. Consumables, instruments, software, and services make up the type segment’s subcategories. With a market size of USD 3.51 billion in 2020, the consumables category had the lion’s share of the global HIV diagnosis market. While HIV can typically be found 18 to 45 days after exposure using an antigen/antibody test conducted by a lab on blood from a vein. Additionally, a quick finger-stick antigen/antibody test is available. Testing for antigens and antibodies using fingerstick blood can take anywhere between 18 and 90 days following exposure. HIV Diagnosis Reagent kits are test kits that can be used in a lab setting or out in the field to find specific compounds. They are frequently employed to check for the usage of illegal substances. Reagent test kits are frequently easy to use and frequently feature color changes to indicate the presence of particular drugs.

Antibody Tests, CD4 Count, Viral Load, Early Infant, and Viral Identification are the test types of the HIV Diagnosis Market. The Antibody Tests Segment held the biggest market share of these and is anticipated to grow at a respectable CAGR over the course of the projected period. In a person’s blood or oral fluid, antibody testing checks for antibodies to HIV. After exposure, it may take 23 to 90 days for antibody testing to identify HIV. Antibody testing is the fastest test and the only HIV self-tests authorized by the FDA. The sector for antibody tests is further separated into tests for HIV-1 detection, HIV-1 confirmation, and tests for HIV-2 and group O. In 2016, it is anticipated that the antibody testing market segment would hold the greatest market share. This high percentage can be linked to the development of HIV diagnosis technology, the rise in HIV awareness, and the increase in blood donations. CD4 Count is the usual range for CD4 counts is 500 to 1500 cells/mm3. Levels can fall to 200 cells/mm3 if a patient is not given treatment, which is one sign that AIDS is present. The segment “viral load” describes the quantity of virus present in a host’s blood. The number of viral particles per milliliter of blood is how this is measured. Higher viral loads might signal different things for different viruses, but they often indicate that the infection is advancing. The early baby diagnosis can act as a link between prevention, care, and treatment—as well as a way to evaluate how well programs for the prevention of mother-to-child transmission (PMTCT) are working. The segment viral identification either RT-PCR on extracts of cell supernatants using certain primers or probes, or indirect immunofluorescence of virus-infected cells employing group- and type-specific monoclonal antibodies, are used to identify viruses.

On the basis of application, HIV Diagnosis Market is subdivided into Diagnostic Laboratories, Hospitals, Blood Banks, and Home Care Settings. For testing carried out in laboratories, antigen/antibody tests are advised and are popular in the US. HIV can typically be found 18 to 45 days after exposure using an antigen/antibody test conducted by a lab on blood from a vein. Additionally, a quick finger-stick antigen/antibody test is available. For HIV Diagnosis in Hospitals, there is the ELISA Test is the main test for detecting HIV and AIDS. Enzyme-linked immunosorbent test, or ELISA, is used to find HIV infection. The Western blot test is typically used to confirm the diagnosis if an ELISA test is positive. In blood banks, your blood donation will be examined for hepatitis and HIV infections. In two weeks, you will receive the results of these tests (and no one else). you have malaria or another sexually transmitted disease, or you are pregnant.

HIV Diagnosis Market Players:

The major players operating in the global HIV diagnosis industry include the major market players are Siemens AG, BD, Roche Diagnostics, Abbott Laboratories, Danaher Corporation, Thermo-Fisher Scientific Inc., Merck KGaA, Becton, Dickinson and Company, Hologic, Inc., Alere Inc., Bio-Rad Laboratories and other

Recent News:

8 May 2023: A new healthcare sector collaboration in Denmark will evaluate the feasibility of recycling used blood collection tubes to reduce medical waste as part of the participants’ sustainability goals and Denmark’s Climate Action Strategy.
13 September 2022: BD Launched Next Generation Prefillable Vaccine Syringe Designed for Reliability, Efficiency.

Who Should Buy? Or Key stakeholders

Manufacturing
End-Use Industries
BFSI
Automotive
Manufacturing & Construction
Regulatory Authorities
Research Organizations
Information Technology
Materials & Chemicals
Otehrs

HIV Diagnosis Market Regional Analysis:

Geographically, the HIV diagnosis market is segmented into North America, South America, Europe, APAC, and MEA.

North America: includes the US, Canada, Mexico
Europe: includes the UK, Germany, France, Italy, Spain, Russia, and the Rest of Europe
Asia Pacific: includes China, Japan, South Korea, India, Australia, ASEAN, and the Rest of APAC
South America: includes Brazil, Argentina, and the Rest of South America
Middle East & Africa: includes Turkey, UAE, Saudi Arabia, South Africa, and the Rest of MEA

In 2020, 38% of the market was accounted for by the North American region. One of the main factors boosting the market in the North America area is the rising prevalence of HIV/AIDS in nations like the U.S. and Canada. Additionally, the presence of significant market participants in the area has contributed to the market’s expansion in the North American region. HIV Diagnosis Market statistics in the region are improving as a result of an increase in HIV/AIDS cases, the presence of important vendors, and increased R&D spending. So, North America dominates the largest market for the HIV Diagnosis market.

Key Market Segments: HIV Diagnosis Market

HIV Diagnosis Market by Product Type, 2020-2029, (USD Billion)

Consumables
Assay
Kits and Reagents

HIV Diagnosis Market by Test Type, 2022-2029, (USD Billion)

Antibody Tests
CD4 Count
Viral Load
Early Infant
Viral Identification

HIV Diagnosis Market by Application, 2022-2029, (USD Billion)

Diagnostic Laboratories
Hospitals
Blood Banks
Home Care Settings

HIV Diagnosis Market by Region, 2022-2029, (USD Billion)

North America
Europe
Asia Pacific
South America
Middle East and Africa

Important Countries in All Regions Are Covered

Exactitude Consultancy Services Key Objectives:

Increasing sales and market share
Developing new technology
Improving profitability
Entering new markets
Enhancing brand reputation

Key Question Answered:

What is the expected growth rate of the HIV diagnosis market over the next 7 years?
Who are the major players in the HIV diagnosis market and what is their market share?
What are the end-user industries driving demand for the market and what is their outlook?
What are the opportunities for growth in emerging markets such as Asia-Pacific, the middle east, and Africa?
How is the economic environment affecting the HIV diagnosis market, including factors such as interest rates, inflation, and exchange rates?
What is the expected impact of government policies and regulations on the HIV diagnosis market?
What is the current and forecasted size and growth rate of the global HIV diagnosis market?
What are the key drivers of growth in the HIV diagnosis market?
Who are the major players in the market and what is their market share?
What are the distribution channels and supply chain dynamics in the HIV diagnosis market?
What are the technological advancements and innovations in the HIV diagnosis market and their impact on product development and growth?
What are the regulatory considerations and their impact on the market?
What are the challenges faced by players in the HIV diagnosis market and how are they addressing these challenges?
What are the opportunities for growth and expansion in the HIV diagnosis market?
What are the services offerings and specifications of leading players in the market?

INTRODUCTION
1. MARKET DEFINITION
2. MARKET SEGMENTATION
3. RESEARCH TIMELINES
4. ASSUMPTIONS AND LIMITATIONS
RESEARCH METHODOLOGY
1. DATA MINING
  1. SECONDARY RESEARCH
  2. PRIMARY RESEARCH
  3. SUBJECT-MATTER EXPERTS’ ADVICE
2. QUALITY CHECKS
  1. FINAL REVIEW
3. DATA TRIANGULATION
  1. BOTTOM-UP APPROACH
  2. TOP-DOWN APPROACH
  3. RESEARCH FLOW
4. DATA SOURCES
EXECUTIVE SUMMARY
MARKET OVERVIEW
1. GLOBAL HIV DIAGNOSIS MARKET OUTLOOK
  1. MARKET DRIVERS
  2. MARKET RESTRAINTS
  3. MARKET OPPORTUNITIES
2. IMPACT OF COVID-19 ON THE HIV DIAGNOSIS MARKET
3. PORTER’S FIVE FORCES MODEL
  1. THREAT FROM NEW ENTRANTS
  2. THREAT FROM SUBSTITUTES
  3. BARGAINING POWER OF SUPPLIERS
  4. BARGAINING POWER OF CUSTOMERS
  5. DEGREE OF COMPETITION
4. INDUSTRY VALUE CHAIN ANALYSIS
GLOBAL HIV DIAGNOSIS MARKET BY PRODUCT TYPE, 2020-2029, (USD BILLION)
1. CONSUMABLES
2. ASSAY
3. KITS AND REAGENTS
GLOBAL HIV DIAGNOSIS MARKET BY TEST TYPE, 2020-2029, (USD BILLION)
1. ANTIBODY TESTS
2. CD4 COUNT
3. VIRAL LOAD
4. EARLY INFANT
5. VIRAL IDENTIFICATION
GLOBAL HIV DIAGNOSIS MARKET BY APPLICATION, 2020-2029, (USD BILLION)
1. DIAGNOSTIC LABORATORIES
2. HOSPITALS
3. BLOOD BANKS
4. HOME CARE SETTINGS
GLOBAL HIV DIAGNOSIS MARKET BY REGION, 2020-2029, (USD BILLION)
1. NORTH AMERICA
  1. US
  2. CANADA
  3. MEXICO
2. SOUTH AMERICA
  1. BRAZIL
  2. ARGENTINA
  3. COLOMBIA
  4. REST OF SOUTH AMERICA
3. EUROPE
  1. GERMANY
  2. UK
  3. FRANCE
  4. ITALY
  5. SPAIN
  6. RUSSIA
  7. REST OF EUROPE
4. ASIA PACIFIC
  1. INDIA
  2. CHINA
  3. JAPAN
  4. SOUTH KOREA
  5. AUSTRALIA
  6. SOUTH-EAST ASIA
  7. REST OF ASIA PACIFIC
5. MIDDLE EAST AND AFRICA
  1. UAE
  2. SAUDI ARABIA
  3. SOUTH AFRICA
  4. REST OF MIDDLE EAST AND AFRICA

COMPANY PROFILES*

(BUSINESS OVERVIEW, COMPANY SNAPSHOT, PRODUCTS OFFERED, RECENT DEVELOPMENTS)

1. SIEMENS AG
2. ROCHE DIAGNOSTICS
3. ABBOTT LABORATORIES
4. DANAHER CORPORATION
5. THERMO-FISHER SCIENTIFIC INC.
6. MERCK KGAA
7. BECTON
8. DICKINSON AND COMPANY
9. HOLOGIC, INC.
10. ALERE INC.
11. BIO-RAD LABORATORIES

*THE COMPANY LIST IS INDICATIVE

LIST OF TABLES

TABLE 1 GLOBAL HIV DIAGNOSIS MARKET BY PRODUCT TYPE (USD BILLION) 2020-2029

TABLE 2 GLOBAL HIV DIAGNOSIS MARKET BY TEST TYPE (USD BILLION) 2020-2029

TABLE 3 GLOBAL HIV DIAGNOSIS MARKET BY APPLICATION (USD BILLION) 2020-2029

TABLE 4 GLOBAL HIV DIAGNOSIS MARKET BY REGION (USD BILLION) 2020-2029

TABLE 5 NORTH AMERICA HIV DIAGNOSIS MARKET BY PRODUCT TYPE (USD BILLION) 2020-2029

TABLE 6 NORTH AMERICA HIV DIAGNOSIS MARKET BY TEST TYPE (USD BILLION) 2020-2029

TABLE 7 NORTH AMERICA HIV DIAGNOSIS MARKET BY APPLICATION (USD BILLION) 2020-2029

TABLE 8 NORTH AMERICA HIV DIAGNOSIS MARKET BY COUNTRY (USD BILLION) 2020-2029

TABLE 9 US HIV DIAGNOSIS MARKET BY PRODUCT TYPE (USD BILLION) 2020-2029

TABLE 10 US HIV DIAGNOSIS MARKET BY TEST TYPE (USD BILLION) 2020-2029

TABLE 11 US HIV DIAGNOSIS MARKET BY APPLICATION (USD BILLION) 2020-2029

TABLE 12 CANADA HIV DIAGNOSIS MARKET BY PRODUCT TYPE (USD BILLION) 2020-2029

TABLE 13 CANADA HIV DIAGNOSIS MARKET BY TEST TYPE (USD BILLION) 2020-2029

TABLE 14 CANADA HIV DIAGNOSIS MARKET BY APPLICATION (USD BILLION) 2020-2029

TABLE 15 MEXICO HIV DIAGNOSIS MARKET BY PRODUCT TYPE (USD BILLION) 2020-2029

TABLE 16 MEXICO HIV DIAGNOSIS MARKET BY TEST TYPE (USD BILLION) 2020-2029

TABLE 17 MEXICO HIV DIAGNOSIS MARKET BY APPLICATION (USD BILLION) 2020-2029

TABLE 18 SOUTH AMERICA HIV DIAGNOSIS MARKET BY PRODUCT TYPE (USD BILLION) 2020-2029

TABLE 19 SOUTH AMERICA HIV DIAGNOSIS MARKET BY TEST TYPE (USD BILLION) 2020-2029

TABLE 20 SOUTH AMERICA HIV DIAGNOSIS MARKET BY APPLICATION (USD BILLION) 2020-2029

TABLE 21 SOUTH AMERICA HIV DIAGNOSIS MARKET BY COUNTRY (USD BILLION) 2020-2029

TABLE 22 BRAZIL HIV DIAGNOSIS MARKET BY PRODUCT TYPE (USD BILLION) 2020-2029

TABLE 23 BRAZIL HIV DIAGNOSIS MARKET BY TEST TYPE (USD BILLION) 2020-2029

TABLE 24 BRAZIL HIV DIAGNOSIS MARKET BY APPLICATION (USD BILLION) 2020-2029

TABLE 25 ARGENTINA HIV DIAGNOSIS MARKET BY PRODUCT TYPE (USD BILLION) 2020-2029

TABLE 26 ARGENTINA HIV DIAGNOSIS MARKET BY TEST TYPE (USD BILLION) 2020-2029

TABLE 27 ARGENTINA HIV DIAGNOSIS MARKET BY APPLICATION (USD BILLION) 2020-2029

TABLE 28 COLOMBIA HIV DIAGNOSIS MARKET BY PRODUCT TYPE (USD BILLION) 2020-2029

TABLE 29 COLOMBIA HIV DIAGNOSIS MARKET BY TEST TYPE (USD BILLION) 2020-2029

TABLE 30 COLOMBIA HIV DIAGNOSIS MARKET BY APPLICATION (USD BILLION) 2020-2029

TABLE 31 REST OF SOUTH AMERICA HIV DIAGNOSIS MARKET BY PRODUCT TYPE (USD BILLION) 2020-2029

TABLE 32 REST OF SOUTH AMERICA HIV DIAGNOSIS MARKET BY TEST TYPE (USD BILLION) 2020-2029

TABLE 33 REST OF SOUTH AMERICA HIV DIAGNOSIS MARKET BY APPLICATION (USD BILLION) 2020-2029

TABLE 34 ASIA-PACIFIC HIV DIAGNOSIS MARKET BY PRODUCT TYPE (USD BILLION) 2020-2029

TABLE 35 ASIA-PACIFIC HIV DIAGNOSIS MARKET BY TEST TYPE (USD BILLION) 2020-2029

TABLE 36 ASIA-PACIFIC HIV DIAGNOSIS MARKET BY APPLICATION (USD BILLION) 2020-2029

TABLE 37 ASIA-PACIFIC HIV DIAGNOSIS MARKET BY COUNTRY (USD BILLION) 2020-2029

TABLE 38 INDIA HIV DIAGNOSIS MARKET BY PRODUCT TYPE (USD BILLION) 2020-2029

TABLE 39 INDIA HIV DIAGNOSIS MARKET BY TEST TYPE (USD BILLION) 2020-2029

TABLE 40 INDIA HIV DIAGNOSIS MARKET BY APPLICATION (USD BILLION) 2020-2029

TABLE 41 CHINA HIV DIAGNOSIS MARKET BY PRODUCT TYPE (USD BILLION) 2020-2029

TABLE 42 CHINA HIV DIAGNOSIS MARKET BY TEST TYPE (USD BILLION) 2020-2029

TABLE 43 CHINA HIV DIAGNOSIS MARKET BY APPLICATION (USD BILLION) 2020-2029

TABLE 44 JAPAN HIV DIAGNOSIS MARKET BY PRODUCT TYPE (USD BILLION) 2020-2029

TABLE 45 JAPAN HIV DIAGNOSIS MARKET BY TEST TYPE (USD BILLION) 2020-2029

TABLE 46 JAPAN HIV DIAGNOSIS MARKET BY APPLICATION (USD BILLION) 2020-2029

TABLE 47 SOUTH KOREA HIV DIAGNOSIS MARKET BY PRODUCT TYPE (USD BILLION) 2020-2029

TABLE 48 SOUTH KOREA HIV DIAGNOSIS MARKET BY TEST TYPE (USD BILLION) 2020-2029

TABLE 49 SOUTH KOREA HIV DIAGNOSIS MARKET BY APPLICATION (USD BILLION) 2020-2029

TABLE 50 AUSTRALIA HIV DIAGNOSIS MARKET BY PRODUCT TYPE (USD BILLION) 2020-2029

TABLE 51 AUSTRALIA HIV DIAGNOSIS MARKET BY TEST TYPE (USD BILLION) 2020-2029

TABLE 52 AUSTRALIA HIV DIAGNOSIS MARKET BY APPLICATION (USD BILLION) 2020-2029

TABLE 53 SOUTH-EAST ASIA HIV DIAGNOSIS MARKET BY PRODUCT TYPE (USD BILLION) 2020-2029

TABLE 54 SOUTH-EAST ASIA HIV DIAGNOSIS MARKET BY TEST TYPE (USD BILLION) 2020-2029

TABLE 55 SOUTH-EAST ASIA HIV DIAGNOSIS MARKET BY APPLICATION (USD BILLION) 2020-2029

TABLE 56 REST OF ASIA PACIFIC HIV DIAGNOSIS MARKET BY PRODUCT TYPE (USD BILLION) 2020-2029

TABLE 57 REST OF ASIA PACIFIC HIV DIAGNOSIS MARKET BY TEST TYPE (USD BILLION) 2020-2029

TABLE 58 REST OF ASIA PACIFIC HIV DIAGNOSIS MARKET BY APPLICATION (USD BILLION) 2020-2029

TABLE 59 EUROPE HIV DIAGNOSIS MARKET BY PRODUCT TYPE (USD BILLION) 2020-2029

TABLE 60 EUROPE HIV DIAGNOSIS MARKET BY TEST TYPE (USD BILLION) 2020-2029

TABLE 61 EUROPE HIV DIAGNOSIS MARKET BY APPLICATION (USD BILLION) 2020-2029

TABLE 62 EUROPE HIV DIAGNOSIS MARKET BY COUNTRY (USD BILLION) 2020-2029

TABLE 63 GERMANY HIV DIAGNOSIS MARKET BY PRODUCT TYPE (USD BILLION) 2020-2029

TABLE 64 GERMANY HIV DIAGNOSIS MARKET BY TEST TYPE (USD BILLION) 2020-2029

TABLE 65 GERMANY HIV DIAGNOSIS MARKET BY APPLICATION (USD BILLION) 2020-2029

TABLE 66 UK HIV DIAGNOSIS MARKET BY PRODUCT TYPE (USD BILLION) 2020-2029

TABLE 67 UK HIV DIAGNOSIS MARKET BY TEST TYPE (USD BILLION) 2020-2029

TABLE 68 UK HIV DIAGNOSIS MARKET BY APPLICATION (USD BILLION) 2020-2029

TABLE 69 FRANCE HIV DIAGNOSIS MARKET BY PRODUCT TYPE (USD BILLION) 2020-2029

TABLE 70 FRANCE HIV DIAGNOSIS MARKET BY TEST TYPE (USD BILLION) 2020-2029

TABLE 71 FRANCE HIV DIAGNOSIS MARKET BY APPLICATION (USD BILLION) 2020-2029

TABLE 72 ITALY HIV DIAGNOSIS MARKET BY PRODUCT TYPE (USD BILLION) 2020-2029

TABLE 73 ITALY HIV DIAGNOSIS MARKET BY TEST TYPE (USD BILLION) 2020-2029

TABLE 74 ITALY HIV DIAGNOSIS MARKET BY APPLICATION (USD BILLION) 2020-2029

TABLE 75 SPAIN HIV DIAGNOSIS MARKET BY PRODUCT TYPE (USD BILLION) 2020-2029

TABLE 76 SPAIN HIV DIAGNOSIS MARKET BY TEST TYPE (USD BILLION) 2020-2029

TABLE 77 SPAIN HIV DIAGNOSIS MARKET BY APPLICATION (USD BILLION) 2020-2029

TABLE 78 RUSSIA HIV DIAGNOSIS MARKET BY PRODUCT TYPE (USD BILLION) 2020-2029

TABLE 79 RUSSIA HIV DIAGNOSIS MARKET BY TEST TYPE (USD BILLION) 2020-2029

TABLE 80 RUSSIA HIV DIAGNOSIS MARKET BY APPLICATION (USD BILLION) 2020-2029

TABLE 81 REST OF EUROPE HIV DIAGNOSIS MARKET BY PRODUCT TYPE (USD BILLION) 2020-2029

TABLE 82 REST OF EUROPE HIV DIAGNOSIS MARKET BY TEST TYPE (USD BILLION) 2020-2029

TABLE 83 REST OF EUROPE HIV DIAGNOSIS MARKET BY APPLICATION (USD BILLION) 2020-2029

TABLE 84 MIDDLE EAST AND AFRICA HIV DIAGNOSIS MARKET BY PRODUCT TYPE (USD BILLION) 2020-2029

TABLE 85 MIDDLE EAST AND AFRICA HIV DIAGNOSIS MARKET BY TEST TYPE (USD BILLION) 2020-2029

TABLE 86 MIDDLE EAST AND AFRICA HIV DIAGNOSIS MARKET BY APPLICATION (USD BILLION) 2020-2029

TABLE 87 MIDDLE EAST AND AFRICA HIV DIAGNOSIS MARKET BY COUNTRY (USD BILLION) 2020-2029

TABLE 88 UAE HIV DIAGNOSIS MARKET BY PRODUCT TYPE (USD BILLION) 2020-2029

TABLE 89 UAE HIV DIAGNOSIS MARKET BY TEST TYPE (USD BILLION) 2020-2029

TABLE 90 UAE HIV DIAGNOSIS MARKET BY APPLICATION (USD BILLION) 2020-2029

TABLE 91 SAUDI ARABIA HIV DIAGNOSIS MARKET BY PRODUCT TYPE (USD BILLION) 2020-2029

TABLE 92 SAUDI ARABIA HIV DIAGNOSIS MARKET BY TEST TYPE (USD BILLION) 2020-2029

TABLE 93 SAUDI ARABIA HIV DIAGNOSIS MARKET BY APPLICATION (USD BILLION) 2020-2029

TABLE 94 SOUTH AFRICA HIV DIAGNOSIS MARKET BY PRODUCT TYPE (USD BILLION) 2020-2029

TABLE 95 SOUTH AFRICA HIV DIAGNOSIS MARKET BY TEST TYPE (USD BILLION) 2020-2029

TABLE 96 SOUTH AFRICA HIV DIAGNOSIS MARKET BY APPLICATION (USD BILLION) 2020-2029

TABLE 97 REST OF MIDDLE EAST AND AFRICA HIV DIAGNOSIS MARKET BY PRODUCT TYPE (USD BILLION) 2020-2029

TABLE 98 REST OF MIDDLE EAST AND AFRICA HIV DIAGNOSIS MARKET BY TEST TYPE (USD BILLION) 2020-2029

TABLE 99 REST OF MIDDLE EAST AND AFRICA HIV DIAGNOSIS MARKET BY APPLICATION (USD BILLION) 2020-2029

LIST OF FIGURES

FIGURE 1 MARKET DYNAMICS

FIGURE 2 MARKET SEGMENTATION

FIGURE 3 REPORT TIMELINES: YEARS CONSIDERED

FIGURE 4 DATA TRIANGULATION

FIGURE 5 BOTTOM-UP APPROACH

FIGURE 6 TOP-DOWN APPROACH

FIGURE 7 RESEARCH FLOW

FIGURE 8 GLOBAL HIV DIAGNOSIS MARKET BY PRODUCT TYPE, USD BILLION, 2020-2029

FIGURE 9 GLOBAL HIV DIAGNOSIS MARKET BY TEST TYPE, USD BILLION, 2020-2029

FIGURE 10 GLOBAL HIV DIAGNOSIS MARKET BY APPLICATION, USD BILLION, 2020-2029

FIGURE 11 GLOBAL HIV DIAGNOSIS MARKET BY REGION, USD BILLION, 2020-2029

FIGURE 12 PORTER’S FIVE FORCES MODEL

FIGURE 13 GLOBAL HIV DIAGNOSIS MARKET BY PRODUCT TYPE, USD BILLION, 2021

FIGURE 14 GLOBAL HIV DIAGNOSIS MARKET BY TEST TYPE, USD BILLION, 2021

FIGURE 15 GLOBAL HIV DIAGNOSIS MARKET BY APPLICATION, USD BILLION, 2021

FIGURE 16 GLOBAL HIV DIAGNOSIS MARKET BY REGION, USD BILLION 2021

FIGURE 17 MARKET SHARE ANALYSIS

FIGURE 18 SIEMENS AG: COMPANY SNAPSHOT

FIGURE 19 ROCHE DIAGNOSTICS: COMPANY SNAPSHOT

FIGURE 20 ABBOTT LABORATORIES: COMPANY SNAPSHOT

FIGURE 21 DANAHER CORPORATION: COMPANY SNAPSHOT

FIGURE 22 THERMO-FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT

FIGURE 23 MERCK KGAA: COMPANY SNAPSHOT

FIGURE 24 BECTON: COMPANY SNAPSHOT

FIGURE 25 DICKINSON AND COMPANY: COMPANY SNAPSHOT

FIGURE 26 HOLOGIC, INC.: COMPANY SNAPSHOT

FIGURE 27 ALERE INC.: COMPANY SNAPSHOT

FIGURE 28 BIO-RAD LABORATORIES: COMPANY SNAPSHOT

• What is the worth of the global HIV diagnosis market?

The global HIV diagnosis market was valued at 4.29 billion in 2022 and is projected to reach 8.68 billion by 2029, growing at a CAGR of 10.6% from 2022 to 2029

• Which market segments are covered in the report on the HIV diagnosis market?

Based on product type, test type, application, and region the HIV diagnosis market reports divisions are broken down.

• What is the CAGR of the HIV diagnosis market?

The global HIV diagnosis market registered a CAGR of 10.6% from 2022 to 2029. The industry segment was the highest revenue contributor to the market.

• Which are the top companies to hold the market share in the HIV diagnosis market?

• Which is the largest regional market for the HIV diagnosis market?

In 2020, the North American region held a majority market share of 38%. One of the main factors boosting the market in the North America area is the rising prevalence of HIV/AIDS in nations like the U.S. and Canada.

In-Depth Database

Our Report’s database covers almost all topics of all regions over the Globe.

Recognised Publishing Sources

Tie ups with top publishers around the globe.

Customer Support

Complete pre and post sales
support.

Safe & Secure

Complete secure payment
process.

INTERESTED IN THIS RESEARCH?

Report Outlook

SCOPE OF THE REPORT